4.8 Review

Autophagy and inflammation in chronic respiratory disease

期刊

AUTOPHAGY
卷 14, 期 2, 页码 221-232

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2017.1389823

关键词

asthma; autophagy; chronic obstructive pulmonary disease (COPD); inflammation; pulmonary fibrosis; pulmonary hypertension; sleep apnea; tuberculosis

资金

  1. American Lung Association of the Northeast [RG-348928]
  2. HHS \ NIH \ National Heart, Lung, and Blood Institute (NHBLI) [P01-HL114501, R01-HL079904, P01-HL105339, K99-HL125899, R01-HL055330]
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL125899, R00HL125899, R01HL132198, T32HL134629] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Persistent inflammation within the respiratory tract underlies the pathogenesis of numerous chronic pulmonary diseases including chronic obstructive pulmonary disease, asthma and pulmonary fibrosis. Chronic inflammation in the lung may arise from a combination of genetic susceptibility and environmental influences, including exposure to microbes, particles from the atmosphere, irritants, pollutants, allergens, and toxic molecules. To this end, an immediate, strong, and highly regulated inflammatory defense mechanism is needed for the successful maintenance of homeostasis within the respiratory system. Macroautophagy/autophagy plays an essential role in the inflammatory response of the lung to infection and stress. At baseline, autophagy may be critical for inhibiting spontaneous pulmonary inflammation and fundamental for the response of pulmonary leukocytes to infection; however, when not regulated, persistent or inefficient autophagy may be detrimental to lung epithelial cells, promoting lung injury. This perspective will discuss the role of autophagy in driving and regulating inflammatory responses of the lung in chronic lung diseases with a focus on potential avenues for therapeutic targeting.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据